cbdMD’s self-affirmed GRAS determination for its broad-spectrum CBD is a key milestone for safety, transparency, and trust in the maturing CBD industry.
The CBD category is entering a new phase.
For years, consumers have been surrounded by an overwhelming number of hemp-derived products, brands, claims, and formats. As the category matures, the question is no longer simply which brands can create awareness.
The question is which brands can earn trust.
At cbdMD, trust has always been built around quality, transparency, product consistency, responsible education, and science-backed development. That is why the completion of our self-affirmed Generally Recognized as Safe (GRAS) determination for our proprietary broad spectrum CBD formulation is such an important milestone.
The determination supports the intended use of cbdMD’s broad spectrum CBD products at a daily intake of up to 200 mg of CBD in healthy adults.
More importantly, it reflects years of work to build a deeper scientific foundation behind our products and our brand.
What Self-Affirmed GRAS Means
GRAS stands for Generally Recognized as Safe.
A self-affirmed GRAS determination is a scientific conclusion made by qualified experts based on the safety of an ingredient or formulation under its intended conditions of use.
For cbdMD, this process included a review of available scientific literature and safety data supporting the intended use of our proprietary broad spectrum CBD formulation.
This does not mean the CBD category is simple. It does not mean every CBD product is the same. It does not replace the need for responsible regulation, quality control, compliance review, or consumer education.
What it does mean is that cbdMD has taken a serious, science-led approach to safety substantiation.
Why This Matters for Consumers
Consumers deserve to know that the brands they choose are doing the work behind the scenes.
That means more than attractive packaging or bold marketing.
It means safety research.
Quality systems.
Transparent labeling.
Responsible claims.
Batch testing.
Compliance review.
Scientific discipline.
CBD products are used by adults across a wide range of wellness routines. As the category continues to grow, consumers should expect more from the companies behind those products.
A self-affirmed GRAS determination helps reinforce cbdMD’s commitment to building products around safety, quality, and trust.
Why This Matters for Retailers and Healthcare Stakeholders
Retailers, healthcare professionals, wellness organizations, and category stakeholders are asking increasingly important questions about hemp-derived CBD products.
Who is making the product?
What safety data supports it?
How is it labeled?
What claims are being made?
What quality systems are in place?
Is the company operating responsibly?
These questions matter because the next phase of CBD will require more than demand. It will require credibility.
cbdMD believes science-backed brands with strong safety documentation and responsible communication will be better positioned as the category evolves.
The Role of Bluebird Botanicals
cbdMD’s regulatory science platform was also strengthened through the acquisition of Bluebird Botanicals.
Bluebird brought an established self-affirmed GRAS dossier for a full-spectrum hemp extract into the cbdMD portfolio. cbdMD has continued advancing its own proprietary broad spectrum CBD safety work.
Together, these assets create a stronger foundation across both broad spectrum and full spectrum hemp-derived formulations.
That matters because consumers and partners do not all want the same CBD format. A stronger platform allows cbdMD to support different product types with a deeper commitment to safety, quality, and responsible development.
Science Is Becoming a Brand Advantage
The CBD category has had no shortage of noise.
But as the market matures, science is becoming one of the clearest ways to separate serious brands from short-term operators.
Responsible companies need to be able to support their products with evidence. They need to communicate clearly. They need to avoid irresponsible claims. They need to invest in product quality. They need to build trust with consumers, retailers, and healthcare stakeholders.
For cbdMD, the self-affirmed GRAS determination is part of that broader commitment.
It reflects the kind of discipline we believe the future of hemp-derived wellness will require.
Building the Next Era of Hemp-Derived Wellness
CBD and hemp wellness remain important parts of cbdMD’s foundation.
But the broader opportunity is building a wellness platform rooted in science, transparency, compliance, product quality, and consumer trust.
The completion of this self-affirmed GRAS determination is an important step in that direction.
It supports cbdMD’s belief that the next era of the category will be shaped by companies that do the hard work:
Invest in safety.
Build quality systems.
Educate responsibly.
Support consumers with transparency.
Operate with compliance discipline.
Earn trust every day.
That is the future cbdMD is building toward.
And that is why this milestone matters.
#cbdMD
#CBD
#HempWellness
#GRAS
#ProductQuality
#ConsumerTrust
#WellnessIndustry
#ScienceBackedWellness